Stay updated on PD-1 Inhibitor Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the PD-1 Inhibitor Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-1 Inhibitor Combo in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s footer/interface revision version was updated from v3.5.0 to v3.5.3, indicating a change to the site release rather than to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-25T18:34:45.000Z thumbnail image
  2. Check
    17 days ago
    No Change Detected
  3. Check
    39 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T18:18:03.000Z thumbnail image
  4. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the page, replacing v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-13T18:39:08.000Z thumbnail image
  5. Check
    76 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 in the site. No evident changes to the study content or page layout are visible in the provided screenshots.
    Difference
    0.0%
    Check dated 2026-02-12T02:01:49.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    Minor maintenance update: Revision v3.4.1 was added and v3.4.0 removed, with no impact on study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T21:59:10.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option. Updated the footer with 'Last Update Submitted that Met QC Criteria', 'No FEAR Act data', and 'Revision: v3.4.0'.
    Difference
    0.1%
    Check dated 2026-01-28T19:30:01.000Z thumbnail image

Stay in the know with updates to PD-1 Inhibitor Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-1 Inhibitor Combo in NSCLC Clinical Trial page.